[Authenda Parmaceuticals ]
What we do
Authenda Pharmaceuticals AG focuses on the development of drugs which, though established in the market, present weaknesses that may be improved or corrected.
Hybrid
These products are mainly characterized as hybrid or 505b2 products.
505b2 products
This way we indirectly serve patients having access to better treatments and compliance.
